Valmet strategic review for separation

Valmet Oyj's Board of Directors initiated a strategic review to evaluate a potential separation of its two core businesses, Biomaterial Solutions and Services and Process Performance Solutions, into two standalone publicly listed companies on Nasdaq Helsinki. The review aims to assess whether a separation would create additional shareholder value by enabling each business to pursue growth more independently with sharper management focus and tailored capital allocation. The Board noted that the businesses operate relatively independently, serving different customer industries with distinct drivers. The recent completion of the Severn Group acquisition brought Process Performance Solutions to approximately EUR 1.7 billion in annual net sales. There is no guarantee that the review will result in a separation; the Board will only proceed if clear evidence of enhanced shareholder value is attained. An update is expected by the full-year 2026 results.